Sign up
Pharma Capital

Manx Telecom delivering 'unique' and 'life changing' technology for the hearing impaired

Manx Telecom (LON:MANX) chief executive Gary Lamb speaks to Proactive Investors about the company's progress with its fibre optic cable strategy, as well as discussing the recent launch in the Isle of Man of hearing loss communications product MT clearSound, developed by Goshawk Communications.

Lamb explains, "commercially there's a big market. We're going to launch in the UK next year; there's about 11 million people in the UK with hearing loss, our sweet spot is moderate to severe hearing loss. We're going to aim for about 20% of those customers which is about 600,000 subscribers in around five years. We're also going to push the technology out around the world."


View full MANX profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.